Aleksandra Bołdys

637 total citations
26 papers, 389 citations indexed

About

Aleksandra Bołdys is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Aleksandra Bołdys has authored 26 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Aleksandra Bołdys's work include Diabetes Treatment and Management (11 papers), Lipoproteins and Cardiovascular Health (7 papers) and Liver Disease Diagnosis and Treatment (4 papers). Aleksandra Bołdys is often cited by papers focused on Diabetes Treatment and Management (11 papers), Lipoproteins and Cardiovascular Health (7 papers) and Liver Disease Diagnosis and Treatment (4 papers). Aleksandra Bołdys collaborates with scholars based in Poland. Aleksandra Bołdys's co-authors include Bogusław Okopień, Łukasz Bułdak, Grzegorz Machnik, Rafał Jakub Bułdak, Krzysztof Łabuzek, Marcin Basiak, Dariusz Belowski, Robert Krysiak, Bogdan Marek and Dariusz Kajdaniuk and has published in prestigious journals such as International Journal of Molecular Sciences, The American Journal of the Medical Sciences and Naunyn-Schmiedeberg s Archives of Pharmacology.

In The Last Decade

Aleksandra Bołdys

26 papers receiving 381 citations

Peers

Aleksandra Bołdys
Zhong-Min Liu China
Aya Shiraki Japan
Shiyin Long China
Jie Fang China
Dariusz Belowski Poland
Amir Ghorbani Haghjo Iran
Abass M. Conteh United States
Zhihong Wu China
Xiangjin Xu China
Nagendra Yaluri Finland
Zhong-Min Liu China
Aleksandra Bołdys
Citations per year, relative to Aleksandra Bołdys Aleksandra Bołdys (= 1×) peers Zhong-Min Liu

Countries citing papers authored by Aleksandra Bołdys

Since Specialization
Citations

This map shows the geographic impact of Aleksandra Bołdys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleksandra Bołdys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleksandra Bołdys more than expected).

Fields of papers citing papers by Aleksandra Bołdys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aleksandra Bołdys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleksandra Bołdys. The network helps show where Aleksandra Bołdys may publish in the future.

Co-authorship network of co-authors of Aleksandra Bołdys

This figure shows the co-authorship network connecting the top 25 collaborators of Aleksandra Bołdys. A scholar is included among the top collaborators of Aleksandra Bołdys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleksandra Bołdys. Aleksandra Bołdys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bołdys, Aleksandra, et al.. (2025). Liraglutide Reduces Liver Steatosis and Improves Metabolic Indices in Obese Patients Without Diabetes: A 3-Month Prospective Study. International Journal of Molecular Sciences. 26(12). 5883–5883. 1 indexed citations
2.
Bołdys, Aleksandra, et al.. (2025). Impact of Short-Term Liraglutide Therapy on Non-Invasive Markers of Liver Fibrosis in Patients with MASLD. Metabolites. 15(8). 510–510. 1 indexed citations
3.
4.
Bołdys, Aleksandra, et al.. (2024). Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy. International Journal of Molecular Sciences. 25(15). 8202–8202. 6 indexed citations
5.
Bułdak, Łukasz, et al.. (2023). Inclisiran—A Revolutionary Addition to a Cholesterol-Lowering Therapy. International Journal of Molecular Sciences. 24(7). 6858–6858. 14 indexed citations
6.
Bołdys, Aleksandra, et al.. (2023). Potential Therapeutic Strategies in the Treatment of Metabolic-Associated Fatty Liver Disease. Medicina. 59(10). 1789–1789. 10 indexed citations
7.
Bułdak, Łukasz, Marcin Basiak, Aleksandra Bołdys, et al.. (2022). Insight into the Evolving Role of PCSK9. Metabolites. 12(3). 256–256. 29 indexed citations
8.
9.
Bułdak, Łukasz, Grzegorz Machnik, Aleksandra Bołdys, et al.. (2022). Exenatide prevents statin-related LDL receptor increase and improves insulin secretion in pancreatic beta cells (1.1E7) in a protein kinase A-dependent manner. Journal of Applied Biomedicine. 20(4). 130–140. 9 indexed citations
10.
Bułdak, Łukasz, Bogdan Marek, Dariusz Kajdaniuk, et al.. (2019). Endocrine diseases as causes of secondary hyperlipidemia. Endokrynologia Polska. 70(6). 511–519. 15 indexed citations
11.
Bułdak, Łukasz, et al.. (2019). The impact of exenatide (a GLP‑1 agonist) on markers of inflammation and oxidative stress in normal human astrocytes subjected to various glycemic conditions. Experimental and Therapeutic Medicine. 17(4). 2861–2869. 18 indexed citations
12.
Machnik, Grzegorz, Łukasz Bułdak, Jarosław Ruczyński, et al.. (2018). Monitoring the Transcriptional Activity of Human Endogenous Retroviral HERV-W Family Using PNA Strand Invasion into Double-Stranded DNA. Molecular Biotechnology. 60(2). 124–133. 3 indexed citations
13.
Okopień, Bogusław, Łukasz Bułdak, & Aleksandra Bołdys. (2017). Fibrates in the management of atherogenic dyslipidemia. Expert Review of Cardiovascular Therapy. 15(12). 913–921. 39 indexed citations
14.
Bułdak, Łukasz, Grzegorz Machnik, Rafał Jakub Bułdak, et al.. (2016). Exenatide and metformin express their anti-inflammatory effects on human monocytes/macrophages by the attenuation of MAPKs and NFκB signaling. Naunyn-Schmiedeberg s Archives of Pharmacology. 389(10). 1103–1115. 40 indexed citations
15.
Okopień, Bogusław, Łukasz Bułdak, & Aleksandra Bołdys. (2016). Current and future trends in the lipid lowering therapy. Pharmacological Reports. 68(4). 737–747. 23 indexed citations
16.
Bułdak, Łukasz, Krzysztof Łabuzek, Rafał Jakub Bułdak, et al.. (2015). Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages. Naunyn-Schmiedeberg s Archives of Pharmacology. 388(9). 905–919. 35 indexed citations
17.
Bułdak, Łukasz, Grzegorz Machnik, Rafał Jakub Bułdak, et al.. (2015). Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner. Pharmacological Reports. 68(2). 329–337. 57 indexed citations
18.
Kobielusz‐Gembala, Iwona, et al.. (2013). Pericardium cardiomyopathy, acute autoimmune pancreatitis and periadipose tissue inflammation — autoimmune reaction?. Kardiologia Polska. 71(6). 621–622. 1 indexed citations
19.
Krysiak, Robert, Aleksandra Bołdys, & Bogusław Okopień. (2011). Autoimmune Polyglandular Syndrome Type 2 Induced by Treatment With Interferon Alpha. The American Journal of the Medical Sciences. 341(6). 504–507. 9 indexed citations
20.
Bołdys, Aleksandra & Bogusław Okopień. (2009). Inhibitors of type 2 sodium glucose co-transporters – a new strategy for diabetes treatment. Pharmacological Reports. 61(5). 778–784. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhong-Min Liu Breakdown of academic impact, for papers by Aya Shiraki Breakdown of academic impact, for papers by Shiyin Long Breakdown of academic impact, for papers by Jie Fang Breakdown of academic impact, for papers by Dariusz Belowski Breakdown of academic impact, for papers by Amir Ghorbani Haghjo Breakdown of academic impact, for papers by Abass M. Conteh Breakdown of academic impact, for papers by Zhihong Wu Breakdown of academic impact, for papers by Xiangjin Xu Breakdown of academic impact, for papers by Nagendra Yaluri
Rankless by CCL
2026